PFBT
UTHR icon

Parkside Financial Bank & Trust’s United Therapeutics UTHR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71K Sell
131
-5
-4% -$2.82K ﹤0.01% 891
2026
Q1 		$80.6K Hold
136
– – 0.01% 774
2025
Q4 		$66.3K Buy
136
+17
+14% +$7.92K 0.01% 855
2025
Q3 		$49.9K Buy
119
+12
+11% +$4.04K ﹤0.01% 938
2025
Q2 		$30.7K Buy
107
+4
+4% +$1.2K ﹤0.01% 1069
2025
Q1 		$31.8K Buy
103
+33
+47% +$11.3K ﹤0.01% 976
2024
Q4 		$24.7K Buy
70
+3
+4% +$1.1K ﹤0.01% 1022
2024
Q3 		$24K Buy
67
+1
+2% +$338 ﹤0.01% 1013
2024
Q2 		$21K Hold
66
– – ﹤0.01% 1016
2024
Q1 		$15.2K Buy
66
+23
+53% +$5.19K ﹤0.01% 1076
2023
Q4 		$9.46K Sell
43
-20
-32% -$4.61K ﹤0.01% 1155
2023
Q3 		$14.2K Hold
63
– – ﹤0.01% 1014
2023
Q2 		$13.9K Sell
63
-6
-9% -$1.33K ﹤0.01% 1012
2023
Q1 		$15.5K Sell
69
-130
-65% -$32K ﹤0.01% 962
2022
Q4 		$55.3K Buy
199
+96
+93% +$24.2K 0.02% 536
2022
Q3 		$22K Hold
103
– – 0.01% 783
2022
Q2 		$24K Buy
+103
New +$20.9K 0.01% 761
2015
Q4 		– Sell
-45
Closed -$6K – 1127
2015
Q3 		$6K Buy
+45
New +$7.22K ﹤0.01% 760

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Parkside Financial Bank & Trust's UTHR Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its United Therapeutics (UTHR) stake by 3.7% in Q2 2026, selling an estimated $2.82K and leaving 131 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Parkside Financial Bank & Trust first reported a position in UTHR in Q3 2015 and has held it in 18 quarters since. The position peaked at $80.6K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Parkside Financial Bank & Trust held 131 shares of United Therapeutics worth $71K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 5 United Therapeutics shares in Q2 2026, an estimated $2.82K.
  • United Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #891 holding.
  • Parkside Financial Bank & Trust first reported a position in United Therapeutics in Q3 2015 and has held it in 18 quarters since.
  • Parkside Financial Bank & Trust's United Therapeutics position peaked at $80.6K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.